Pharmaceutical Training Course Calendar

Back to details

Training format

Topic

Our Pharmaceutical calendar for the next 12 months:

Live online Classroom 2024 2025
Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct
A Practical Guide to Producing and Maintaining the PSMF Vigilance 14 23 3
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 5 21 11
AI in Pharmacovigilance Vigilance 12 7
Additional Risk Minimization Measures (aRMMs) and Their Effectiveness Vigilance 4 9 10
Advanced Pharmacovigilance Vigilance 9-13 24-26 2-4 6-10
Advanced Project Management in Clinical Research Clinical Research 11 9 3
Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Leadership & Strategy 18-19 6-7 3-4
An Essential Overview of Medical Information Regulatory Affairs 29 14 18
An Essential Overview of Pharmacovigilance Vigilance 27 15 8-9
An Essential Overview of the Medical Device Industry Regulatory Affairs 14 3
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 16 12 22
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 17 9
An Introduction to Pharmaceutical Packaging GxP 13-15 2-4 24-26
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Regulatory Affairs 9 17
Best Practice for Writing Effective SOPs Regulatory Affairs 12 27 17
Best Practices for Supplier Qualification in Life Science GxP 7-8 27-28 16-17
Biosimilars Biopharma 30-31 21-22 30-1
Biotechnology for the Non-Biotechnologist Biopharma 2-6
Building Better Health via Digitalised and Personalised Patient Support Programmes Clinical Research 12 2
CAPA (Corrective and Preventative Action) Regulatory Affairs 13 28 18
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 27-28 26-27 20-21
Cleaning Validation Best Practice in Pharmaceuticals GxP 5-6 8-9 8-9
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 5-6 18-19 1-2
Clinical Quality Management Systems Clinical Research 23-24 22-23 18-19
Clinical Trial Monitoring Clinical Research 2-3 28-29 21-22
Clinical Trial Regulatory Requirements Clinical Research 20-21 8-9 15-16
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Clinical Research 19 17
Cosmetovigilance Vigilance 3-4 19-20 13-14
Data Integrity Auditor Masterclass GxP 4-5 12-13 15-16
Data Integrity and Document Management GxP 6 7 14
Development of Combination Products: Critical Interactions GxP 10-11 24-25 2-3
Drafting Commercial Contracts for the Pharmaceutical Industry Commercial Contracts 20-21
Drug Discovery: A Step-by-Step Introduction Medical Technology 23-24 8-9 18-19
EU Clinical Trial Regulation 536/2014: Overview and Implementation Experience Clinical Research 13-14 2-3 13-14
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 10-11 9-10 6-7
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 20 19 16
Effective Technical Writing & Editing Medical Writing 5 5 1
Effective Technology Transfer GxP 3-4 2-3 6-7
Effective Training Skills in the Pharma Industry Coaching & Mentoring 27-28 26-27 9-10
European Post Marketing Pharmacovigilance - Including the EMA/PRAC Deliberations and Brexit Implications Vigilance 3-7 14-16
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 22 14 1
GMP Principles in Vaccine Manufacturing GxP 16-17 10-11
Global Pharmaceutical Regulatory Affairs Summer School Regulatory Affairs 9-13
Good Distribution Practices of Pharmaceuticals and APIs GxP 17-18 9-10
ICH Q9(R1) Quality Risk Management (QRM) GxP 29 12 9
Introduction to Good Clinical Practice (GCP) GxP 11-12 24-25 7-8
MBA Strategic Thinking for Pharma and Biopharma Professionals Leadership & Strategy 24-25 16-17 2-3
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Clinical Research 6-7 23-24 16-17
Metrics and Earned Value in Clinical Research Projects Clinical Research 25 5 22
Microbiomics in Clinical Trials Clinical Research 27 4 14
Navigating China’s API Regulations: An Essential Guide to DMF Registration GxP 12 23 23
Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products Regulatory Affairs 21-22 19-20 10-11
New EU GMP Annex 1: Compliant Aseptic Operations GxP 26-28 11-13 1-3
Pharmaceutical Development of ATMPs GxP 3-4 17-18 13-14
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 19-20 24-25 16-17 21-22
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 25-27 11-13 8-10
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 10-11 31-1 25-26
Pharmaceutical Regulatory Affairs in Latin America Regulatory Affairs 25 18 22
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 6-7 19-20 2-3
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 9-10 25-26 23-24 21-22
Pharmacovigilance Vigilance 5-7 11-13 15-17
Pharmacovigilance Aspects of Licensing Agreements Vigilance 27-28 10 1
Pharmacovigilance QMS & Inspection Preparation Vigilance 20-21 19-20 25-26
Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors – Broadening your Knowledge Vigilance 29-31 7-9 29-1
Positive Persuading and Influencing Skills for Pharma Professionals Management 11-14 17-18 7-8
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 10-11 12-13 16-17
Process Validation with Qualification GxP 13-14 20-21 22-23
Project Management for Pharma Professionals Project Management 9-10 10-11 24-25
Real World Evidence (RWE), Real World Data (RWD) and the Application of Artificial Intelligence (AI) in The Pharmaceutical Market Clinical Research 26 16
Regulatory Affairs for Support Staff Regulatory Affairs 27-28 12-13 22-23
Regulatory Strategies for Orphan Drugs Regulatory Affairs 10 23 7
Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP) Vigilance 15 21 24
Risk Management for Pharma and Biopharma Professionals Regulatory Affairs 4 6 7
Root Cause Analysis and Critical Thinking Management 25 13 15
Signal Detection and Regulatory Expectations Vigilance 12-15 17-18 7-8
Smart Packaging and Electronic Patient Information GxP 4-5 13 2
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 11-12 24-27 21-22
Successful Medical Writing – from Protocol to CTD Medical Writing 16-17 5-6 25-26
The Advancement of Research and Development (R&D) Clinical Trials using Software Automation Clinical Research 12 4 1
The Common Technical Document GxP 25-26 11-12 7-8
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 28 13 1
The FDA Drug Approval Process Regulatory Affairs 2-3 24-25 11-12 7-8
The Importance of Patient Adherence Data and How Digital Tools Can Improve Patient Outcomes Clinical Research 26 18 15
The Leadership and Management Summer School for Pharma Professionals Leadership & Strategy 7-11
The Pharma Mini MBA Leadership & Strategy 6-8 19-21 9-11
The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Regulatory Affairs 13-14 12-13 13-14
Thinking Outside of the GMP Box GxP 14-15 13-14 17-18
US FDA - Understanding Key Factors When Working with the FDA Biopharma 27 13 11
Understanding Active Pharmaceutical Ingredients (APIs) GxP 25-26 16-17
Understanding Computer System Validation (CSV) GxP 18-19 9-10
Understanding Pharmacovigilance Regulations in APAC Vigilance 13-14 16-17 9-10
Variations to Marketing Authorisations Regulatory Affairs 28-29 6-7 3-4 15-16
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Leadership & Strategy 10 30 20